Oncogenic Alternative Splicing Switches: Role in Cancer Progression and Prospects for Therapy
Open Access
- 27 October 2013
- journal article
- review article
- Published by Hindawi Limited in International Journal of Cell Biology
- Vol. 2013, 1-17
- https://doi.org/10.1155/2013/962038
Abstract
Alterations in the abundance or activities of alternative splicing regulators generate alternatively spliced variants that contribute to multiple aspects of tumor establishment, progression and resistance to therapeutic treatments. Notably, many cancer-associated genes are regulated through alternative splicing suggesting a significant role of this post-transcriptional regulatory mechanism in the production of oncogenes and tumor suppressors. Thus, the study of alternative splicing in cancer might provide a better understanding of the malignant transformation and identify novel pathways that are uniquely relevant to tumorigenesis. Understanding the molecular underpinnings of cancer-associated alternative splicing isoforms will not only help to explain many fundamental hallmarks of cancer, but will also offer unprecedented opportunities to improve the efficacy of anti-cancer treatments.Keywords
This publication has 143 references indexed in Scilit:
- Post-transcriptional regulation in cancer progressionJournal of Cell Communication and Signaling, 2012
- WT1 Mutants Reveal SRPK1 to Be a Downstream Angiogenesis Target by Altering VEGF SplicingCancer Cell, 2011
- Tumor Metastasis: Molecular Insights and Evolving ParadigmsCell, 2011
- Basic and Therapeutic Aspects of AngiogenesisCell, 2011
- Twist1-Induced Invadopodia Formation Promotes Tumor MetastasisCancer Cell, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Characterization of the expression, localization, and secretion of PANDER in α-cellsMolecular and Cellular Endocrinology, 2010
- Epithelial-Mesenchymal Transitions in Development and DiseaseCell, 2009
- A Mena Invasion Isoform Potentiates EGF-Induced Carcinoma Cell Invasion and MetastasisDevelopmental Cell, 2008
- Identification of invasion specific splice variants of the cytoskeletal protein Mena present in mammary tumor cells during invasion in vivoClinical & Experimental Metastasis, 2008